Xi'an Mokemei Biotechnology: difference between revisions
Diff·revision 20 → 21·01:36, 6 Jun 2025
Difference between revision 20 and revision 21 of Xi'an Mokemei Biotechnology. 9 lines changed; the page grew by 630 bytes.
| Revision 20 — 12:26, 31 May 2025 CategoryBot (talk) bot: expand DOI to full citation 5,169 bytes ±0 | Revision 21 — 01:36, 6 Jun 2025 VerifyVesna (talk) attribute range as a review estimate per talk 5,799 bytes +630 | ||
|---|---|---|---|
| 12 | | Shop domain = [https://mokemeibiotechnology.com/ Visit MKM] | 12 | | Shop domain = [https://mokemeibiotechnology.com/ Visit MKM] |
| 13 | }} | 13 | }} |
| + | 14 | {{hatnote|This article is about the organisation. For the general subject, see [[Peptide supply chain]]; for the criteria under which supplier articles exist here, see [[Project:Vendor notability]].}} | |
| 14 | 15 | ||
| 15 | '''Xi'an Mokemei Biotechnology Co., Ltd.''' (trading as '''MKM'''; mokemeibiotechnology.com) is a research-compound supplier trading as MKM from Xi'an, Shaanxi, China, incorporated in 2016, distributing research peptides, SARMs and raw materials with batch documentation.{{r|registry,selfpub}} | 16 | '''Xi'an Mokemei Biotechnology Co., Ltd.''' (trading as '''MKM'''; mokemeibiotechnology.com) is a research-compound supplier trading as MKM from Xi'an, Shaanxi, China, incorporated in 2016, distributing research peptides, SARMs and raw materials with batch documentation.{{r|registry,selfpub}} |
| ⋮ | ⋮ | ||
| 31 | 32 | ||
| 32 | That observation rests on two reports and is not generalisable. It is stated because omitting it would be a selection decision, not because two reports establish a pattern. | 33 | That observation rests on two reports and is not generalisable. It is stated because omitting it would be a selection decision, not because two reports establish a pattern. |
| + | 34 | ||
| + | 35 | == Product range == | |
| + | 36 | | Class | Representative listings | Documentation reported | | |
| + | 37 | |---|---|---| | |
| + | 38 | | Incretin analogues | Semaglutide, tirzepatide | Certificate, variable content | | |
| + | 39 | | Research peptides | Repair and secretagogue peptides | Certificate, variable content | | |
| + | 40 | | Extract-derived materials | Botanical extracts, standardised | Certificate, assay basis unclear | | |
| + | 41 | | SARMs and raw materials | Bulk | Certificate, purity only | | |
| 33 | 42 | ||
| 34 | == References == | 43 | == References == |